Re: See W, Iversen P, Wirth M, McLeod D, Garside L, Morris T. Immediate treatment with bicalutamide 150 mg as adjuvant therapy significantly reduces the risk of PSA progression in early prostatic cancer. Eur Urol 2003;44:512–8

✍ Scribed by Andrea Tubaro; Cosimo De Nunzio

• Book ID: 113608610
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 45 KB
• Volume: 45
• Category: Article
• ISSN: 0302-2838
• DOI: 10.1016/j.eururo.2004.01.006